Company profile
WINDTREE THERAPEUTICS INC /DE/ CIK 946486
Ticker
WINT
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Warrington, PA 18976
Fiscal year end
2024 (FY)
Key Financials
Revenue
—
Net income
-$1.79M
Total assets
$27.88M
Total liabilities
$14.70M
Stockholders' equity
$10.00M
Cash & equivalents
$1.78M
Operating income
-$26.14M
Operating cash flow
-$15.40M
Capital expenditures
$12.0K
Fiscal year 2024, via 10-K filed 2025-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$15.41M
Free cash flow margin
—
Liabilities / assets
52.7%
Equity / assets
35.9%
CapEx / revenue
—
Operating cash flow / net income
8.62×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
—
-$1.79M
$27.88M
$14.70M
$10.00M
2023
—
-$20.29M
$32.41M
$29.02M
$3.39M
2022
—
-$39.21M
$37.95M
$27.94M
$10.01M
2021
—
-$67.64M
$74.79M
$32.91M
$41.88M
2020
—
-$32.57M
$112.89M
$43.33M
$69.55M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-07-22
Financials filed via
Form 10-K
filed 2025-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Warrington, PA 18976
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:51 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.